About Astex Pharmaceuticals (NASDAQ:SUPG)
Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company. The Company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. It is also engaged in the application of fragment-based drug discovery and development of small-molecule therapeutics. Using its fragment-based drug discovery platform, Pyramid, Astex Therapeutics Limited, a wholly owned subsidiary, has built a pipeline of molecularly-targeted drugs for large pharmaceutical partners and internal development that are at various stages of clinical, pre-clinical and early discovery development. In October 2013, Otsuka Holdings Co Ltd announced that its wholly owned subsidiary, Otsuka Pharmaceutical Co., Ltd completed, through its wholly owned indirect subsidiary Autumn Acquisition Corporation, its acquisition of Astex Pharmaceuticals, Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Astex Pharmaceuticals (NASDAQ:SUPG) Frequently Asked Questions
What is Astex Pharmaceuticals' stock symbol?
Astex Pharmaceuticals trades on the NASDAQ under the ticker symbol "SUPG."
Has Astex Pharmaceuticals been receiving favorable news coverage?
Headlines about SUPG stock have been trending somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Astex Pharmaceuticals earned a coverage optimism score of 0.12 on Accern's scale. They also gave media coverage about the healthcare company an impact score of 45.99 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
How do I buy shares of Astex Pharmaceuticals?
Shares of SUPG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Astex Pharmaceuticals?
Astex Pharmaceuticals' mailing address is Suite 200, 4140 Dublin Blvd., DUBLIN, CA 94568, United States. The healthcare company can be reached via phone at +1-925-5600100.
MarketBeat Community Rating for Astex Pharmaceuticals (SUPG)MarketBeat's community ratings are surveys of what our community members think about Astex Pharmaceuticals and other stocks. Vote "Outperform" if you believe SUPG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SUPG will underperform the S&P 500 over the long term. You may vote once every thirty days.
Astex Pharmaceuticals (NASDAQ:SUPG) Analyst Ratings History
(Data available from 4/23/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Astex Pharmaceuticals (NASDAQ:SUPG) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Astex Pharmaceuticals (NASDAQ SUPG) Insider Trading and Institutional Ownership History
Astex Pharmaceuticals (NASDAQ SUPG) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Astex Pharmaceuticals (NASDAQ SUPG) News Headlines
Astex Pharmaceuticals (NASDAQ:SUPG) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Astex Pharmaceuticals (NASDAQ:SUPG) Income Statement, Balance Sheet and Cash Flow Statement
Astex Pharmaceuticals (NASDAQ SUPG) Stock Chart for Monday, April, 23, 2018